G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression

Cell Mol Life Sci. 2023 May 27;80(6):165. doi: 10.1007/s00018-023-04810-y.

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) is involved in triple-negative breast cancer (TNBC) progression. Metabolic crosstalk between cancer cells and tumor-associated macrophages mediates tumor progression in TNBC. Molecular biological methods were applied to clarify the mechanism of the crosstalk between TNBC cells and M2 macrophages. In the present study, we verified that G6PD overexpression drives M2 macrophage polarization by directly combining with phospho-STAT1 and upregulating CCL2 and TGF-β1 secretion in TNBC cells. In turn, M2-like TAMs activated TNBC cells through IL-10 secretion, providing feedback to upregulate G6PD and promote TNBC cell migration and proliferation in vitro. Furthermore, we found that 6-AN (a specific inhibitor of G6PD) not only suppressed the cancer-driven polarization of macrophages toward the M2 phenotype but also inhibited the inherent M2 polarization of macrophages. Targeting the G6PD-regulated pentose phosphate pathway restrained TNBC progression and M2-type polarization of macrophages in vitro and in vivo.

Keywords: 6-AN; G6PD; M2 macrophages; TNBC.

MeSH terms

  • Cell Line, Tumor
  • Glucosephosphate Dehydrogenase* / genetics
  • Glucosephosphate Dehydrogenase* / metabolism
  • Humans
  • Macrophages / metabolism
  • Triple Negative Breast Neoplasms* / genetics
  • Tumor Microenvironment

Substances

  • Glucosephosphate Dehydrogenase
  • G6PD protein, human